CN110923200A - 一种精子培养液及其制备方法 - Google Patents
一种精子培养液及其制备方法 Download PDFInfo
- Publication number
- CN110923200A CN110923200A CN201911360430.3A CN201911360430A CN110923200A CN 110923200 A CN110923200 A CN 110923200A CN 201911360430 A CN201911360430 A CN 201911360430A CN 110923200 A CN110923200 A CN 110923200A
- Authority
- CN
- China
- Prior art keywords
- sperm
- sodium
- culture solution
- solution
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000000243 solution Substances 0.000 claims abstract description 116
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 54
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims abstract description 50
- 239000002994 raw material Substances 0.000 claims abstract description 43
- BYPFEZZEUUWMEJ-UHFFFAOYSA-N Pentoxifylline Chemical compound O=C1N(CCCCC(=O)C)C(=O)N(C)C2=C1N(C)C=N2 BYPFEZZEUUWMEJ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 229960001476 pentoxifylline Drugs 0.000 claims abstract description 31
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 28
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 27
- 239000008103 glucose Substances 0.000 claims abstract description 27
- 229960003080 taurine Drugs 0.000 claims abstract description 27
- 239000007853 buffer solution Substances 0.000 claims abstract description 24
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000001540 sodium lactate Substances 0.000 claims abstract description 23
- 235000011088 sodium lactate Nutrition 0.000 claims abstract description 23
- 229940005581 sodium lactate Drugs 0.000 claims abstract description 23
- 229940054269 sodium pyruvate Drugs 0.000 claims abstract description 23
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 16
- 239000003899 bactericide agent Substances 0.000 claims abstract description 16
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 16
- 229960001031 glucose Drugs 0.000 claims abstract description 16
- 239000005515 coenzyme Substances 0.000 claims abstract description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 30
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 28
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 27
- 238000004113 cell culture Methods 0.000 claims description 26
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 26
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 25
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 25
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 22
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 15
- 239000001110 calcium chloride Substances 0.000 claims description 15
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 15
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 15
- 239000011780 sodium chloride Substances 0.000 claims description 15
- 235000002639 sodium chloride Nutrition 0.000 claims description 15
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 12
- 235000011148 calcium chloride Nutrition 0.000 claims description 11
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 11
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 11
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 11
- 239000001103 potassium chloride Substances 0.000 claims description 11
- 235000011164 potassium chloride Nutrition 0.000 claims description 11
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000012736 aqueous medium Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 8
- 239000012498 ultrapure water Substances 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 229930182566 Gentamicin Natural products 0.000 claims description 7
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 7
- 229960002518 gentamicin Drugs 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000007640 basal medium Substances 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 4
- 229930182555 Penicillin Natural products 0.000 claims description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 2
- 229940049954 penicillin Drugs 0.000 claims description 2
- 229960005322 streptomycin Drugs 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 230000019100 sperm motility Effects 0.000 abstract description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 10
- 229910052760 oxygen Inorganic materials 0.000 abstract description 10
- 239000001301 oxygen Substances 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 4
- 230000004720 fertilization Effects 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 23
- 230000000694 effects Effects 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 206010067162 Asthenospermia Diseases 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 4
- 208000000509 infertility Diseases 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 231100000535 infertility Toxicity 0.000 description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 description 4
- NGSFWBMYFKHRBD-DKWTVANSSA-M sodium;(2s)-2-hydroxypropanoate Chemical compound [Na+].C[C@H](O)C([O-])=O NGSFWBMYFKHRBD-DKWTVANSSA-M 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 206010003883 azoospermia Diseases 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000004899 motility Effects 0.000 description 3
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical group CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 230000030120 acrosome reaction Effects 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000432 density-gradient centrifugation Methods 0.000 description 2
- 230000000687 effect on sperms Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 208000008634 oligospermia Diseases 0.000 description 2
- 230000036616 oligospermia Effects 0.000 description 2
- 231100000528 oligospermia Toxicity 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical group N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000015494 Mitochondrial Uncoupling Proteins Human genes 0.000 description 1
- 108010050258 Mitochondrial Uncoupling Proteins Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 230000008811 mitochondrial respiratory chain Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- -1 quinone compound Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Abstract
Description
物料 | 浓度 |
NaCl | 98mmol/L |
KC1 | 5.3mmol/L |
NaH<sub>2</sub>P0<sub>4</sub> | 0.25mmol/L |
MgSO<sub>4</sub> | 1mmol/L |
NaHCO<sub>3</sub> | 25mmol/L |
CaCl<sub>2</sub> | 1.9mmol/L |
葡萄糖 | 0.45mmol/L |
乳酸钠 | 10.5mmol/L |
丙酮酸钠 | 0.35mmol/L |
牛磺酸 | 0.11mmol/L |
庆大霉素 | 45mg/L |
辅酶Q10 | 1mg/L |
己酮可可碱 | 1.1g/L |
物料 | 浓度 |
NaCl | 90.08mmol/L |
KC1 | 5.5mmol/L |
NaH<sub>2</sub>P0<sub>4</sub> | 0.25mmol/L |
MgSO<sub>4</sub> | 1mmol/L |
NaHCO<sub>3</sub> | 25mmol/L |
CaCl<sub>2</sub> | 1.8mmol/L |
葡萄糖 | 0.5mmol/L |
乳酸钠 | 10.5mmol/L |
丙酮酸钠 | 0.32mmol/L |
牛磺酸 | 0.1mmol/L |
庆大霉素 | 50mg/L |
己酮可可碱 | 1g/L |
物料 | 浓度 |
NaCl | 90.08mmol/L |
KC1 | 5.5mmol/L |
NaH<sub>2</sub>P0<sub>4</sub> | 0.25mmol/L |
MgSO<sub>4</sub> | 1mmol/L |
NaHCO<sub>3</sub> | 25mmol/L |
CaCl<sub>2</sub> | 1.8mmol/L |
葡萄糖 | 0.5mmol/L |
乳酸钠 | 10.5mmol/L |
丙酮酸钠 | 0.32mmol/L |
牛磺酸 | 0.1mmol/L |
庆大霉素 | 50mg/L |
辅酶Q10 | 1mg/L |
物料 | 浓度 |
NaCl | 90.08mmol/L |
KC1 | 5.5mmol/L |
NaH<sub>2</sub>P0<sub>4</sub> | 0.25mmol/L |
MgSO<sub>4</sub> | 1mmol/L |
NaHCO<sub>3</sub> | 25mmol/L |
CaCl<sub>2</sub> | 1.8mmol/L |
葡萄糖 | 0.5mmol/L |
乳酸钠 | 10.5mmol/L |
丙酮酸钠 | 0.32mmol/L |
牛磺酸 | 0.1mmol/L |
庆大霉素 | 50mg/L |
物料 | 浓度 |
市售的精子培养液 | -- |
辅酶Q10 | 1mg/L |
己酮可可碱 | 1g/L |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911360430.3A CN110923200B (zh) | 2019-12-25 | 2019-12-25 | 一种精子培养液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911360430.3A CN110923200B (zh) | 2019-12-25 | 2019-12-25 | 一种精子培养液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110923200A true CN110923200A (zh) | 2020-03-27 |
CN110923200B CN110923200B (zh) | 2021-08-03 |
Family
ID=69862067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911360430.3A Active CN110923200B (zh) | 2019-12-25 | 2019-12-25 | 一种精子培养液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110923200B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112592888A (zh) * | 2020-12-31 | 2021-04-02 | 深圳英莱生命科学有限公司 | 一种精子培养液及其制备方法 |
CN112608886A (zh) * | 2021-01-05 | 2021-04-06 | 深圳英莱生命科学有限公司 | 卵子与胚胎处理液及其制备方法 |
CN113508807A (zh) * | 2021-08-05 | 2021-10-19 | 信阳农林学院 | 一种卵巢常温保存液及其保存方法 |
CN114686423A (zh) * | 2022-04-29 | 2022-07-01 | 南京优而生物科技发展有限公司 | 一种提高小鼠精子活力的htf培养液制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104046590A (zh) * | 2014-06-18 | 2014-09-17 | 郜鸿生物科技(上海)有限公司 | 一种稀少精子体外培养基 |
CN109628380A (zh) * | 2018-12-25 | 2019-04-16 | 深圳韦拓生物科技有限公司 | 一种人体外受精液及其制备方法 |
-
2019
- 2019-12-25 CN CN201911360430.3A patent/CN110923200B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104046590A (zh) * | 2014-06-18 | 2014-09-17 | 郜鸿生物科技(上海)有限公司 | 一种稀少精子体外培养基 |
CN109628380A (zh) * | 2018-12-25 | 2019-04-16 | 深圳韦拓生物科技有限公司 | 一种人体外受精液及其制备方法 |
Non-Patent Citations (2)
Title |
---|
AHMED T ALAHMAR ET AL.: "The effects of oral antioxidants on the semen of men", 《CLIN EXP REPROD MED》 * |
刘容菊: "辅助生殖技术中预防活性氧对精子的损伤", 《生 殖 与 避 孕》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112592888A (zh) * | 2020-12-31 | 2021-04-02 | 深圳英莱生命科学有限公司 | 一种精子培养液及其制备方法 |
CN112608886A (zh) * | 2021-01-05 | 2021-04-06 | 深圳英莱生命科学有限公司 | 卵子与胚胎处理液及其制备方法 |
CN113508807A (zh) * | 2021-08-05 | 2021-10-19 | 信阳农林学院 | 一种卵巢常温保存液及其保存方法 |
CN114686423A (zh) * | 2022-04-29 | 2022-07-01 | 南京优而生物科技发展有限公司 | 一种提高小鼠精子活力的htf培养液制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110923200B (zh) | 2021-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110923200B (zh) | 一种精子培养液及其制备方法 | |
Evans et al. | Studies of nutrient media for tissue cells in vitro I. A protein-free chemically defined medium for cultivation of strain L cells | |
EP3341473B1 (en) | Culture medium | |
CN111073848B (zh) | 一种卵裂期胚胎培养组合物及卵裂期胚胎培养液 | |
CN108251355B (zh) | 一步式胚胎培养液 | |
JP4202121B2 (ja) | 哺乳動物の配偶子および胚の培養基サプリメント、およびその使用法 | |
VALENTINE et al. | Hemolytic anemias and erythrocyte enzymopathies | |
WO2018189436A1 (fr) | Adjuvants dépourvus de cytokines pour milieux de culture cellulaire notamment pour fécondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons | |
EP2950643A1 (en) | Composition and method for preserving, transporting and storing living biological materials | |
CN108251354B (zh) | 一步式胚胎培养液及其制备方法 | |
Asadpour et al. | Effect of vitamin B12 addition to extenders on some physicochemical parameters of semen in crossbred rams | |
AU2001268308A1 (en) | Mammalian gamete and embryo culture media supplement and method of using same | |
ES2352046T3 (es) | Medio de cultivo celular y procedimiento de cultivo de células madre y células progenitor. | |
CN110951679B (zh) | 一种精子密度梯度离心液及其制备方法 | |
Rappeport et al. | Application of bone marrow transplantation in genetic diseases | |
EP2790499B1 (en) | Culture media for treating female gametes and embryos in medically assisted reproduction techniques | |
CN111040991B (zh) | 一种体外受精液及其制备方法 | |
JP2021532833A (ja) | 細胞および/または組織の輸送用組成物および/または凍結保存用組成物 | |
Lee et al. | Effect of nicotinic acid on fresh semen characteristics in miniature pigs | |
Ling et al. | Chemically characterized concentrated corodies for continuous cell culture (the 7C's culture media) | |
Klebanoff | Glutathione metabolism. 2. The oxidation and reduction of glutathione in intact erythrocytes | |
CN113652400A (zh) | 一种nk细胞无血清培养基及其用途 | |
Cifarelli et al. | The influence of some metabolic inhibitors on phagocytic activity of mouse macrophages in vitro | |
CN111235092B (zh) | 囊胚培养液及其制备方法 | |
CN112481197A (zh) | 一种人精子清洗液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210329 Address after: 528300 room 413, 4th floor, block 22, Shunlian Machinery City, No.18, Xingye 4th Road, Guanglong Industrial Park, Chihua community, Chencun Town, Shunde District, Foshan City, Guangdong Province Applicant after: Foshan Fukang Biotechnology Co.,Ltd. Address before: 510000 room A219, 29 Guangyun Road, Huangshi street, Baiyun District, Guangzhou City, Guangdong Province Applicant before: Guangzhou Yukang Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231124 Address after: Room 601, No. 6 Yonghe Yushan International Rongjing 1st Road, Xintang Town, Zengcheng District, Guangzhou City, Guangdong Province, 511300, self-made A1 Patentee after: GUANGZHOU FUKANG BIOTECHNOLOGY Co.,Ltd. Address before: 528300 room 413, 4th floor, block 22, Shunlian Machinery City, No.18, Xingye 4th Road, Guanglong Industrial Park, Chihua community, Chencun Town, Shunde District, Foshan City, Guangdong Province Patentee before: Foshan Fukang Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |